10-Year Follow-up After Interferon- Therapy for Chronic
Hepatitis C
REFERENCES
1.Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ,
Holland PV. Transfusion-associated hepatitis not due to viral
hepatitis type A or B. N Engl J Med 1975; 292: 767-770[
Medline].
2.Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW,
Houghton M. Isolation of a cDNA clone derived from a blood-borne
non-A, non-B viral hepatitis genome. Science 1989; 244: 359-362[
Medline].
3.Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redeker AG,
Purcell H, Miyamura T, et al. An assay for circulating antibodies
to a major etiologic virus of human non-A, non-B antibodies.
Science 1989; 244: 362-364[
Medline].
4.Weiner AJ, Kuo G, Bradley DW, Bonino F, Saracco G, Lee
C, Rosenblatt J, et al. Detection of hepatitis C viral sequences in
non-A, non-B hepatitis. Lancet 1990; 335: 1-3[
Medline].
5.McQuillan GM, Alter MJ, Moyer LA, Lambert SB, Margolis
HS. A population based serologic study of hepatitis C virus
infection in the United States. In: Rizzetto M, Purcell RH, Gerin
JL, Verme G, eds. Viral Hepatitis and Liver Disease. Turin:
Edizioni Minerva Medica, 1997:267-270.
6.Hoofnagle JH. Hepatitis C: the clinical spectrum of
disease. HEPATOLOGY 1997; 26(Suppl.): 15S-20S[
Medline].
7.Di Bisceglie AM. Hepatitis C and hepatocellular
carcinoma. HEPATOLOGY 1997; 26(Suppl.): 34S-38S[
Medline].
8.Hoofnagle JH, Mullen KD, Jones DB, Rustgi V, Di
Bisceglie A, Peters M, Waggoner JG, et al. Treatment of chronic
non-A, non-B hepatitis with recombinant human alpha-interferon. N
Engl J Med 1986; 315: 1575-1578[
Medline].
9.Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman
M, Murray L, Waggoner J, Goodman Z, et al. Recombinant interferon
alfa therapy for chronic hepatitis C: a randomized, double-blind,
placebo-controlled trial. N Engl J Med 1989; 321: 1506-1510[
Medline].
10.Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer
Jr HC, Perrillo RP, Carey W, et al. Treatment of chronic hepatitis
C with recombinant interferon alfa: a multicenter randomized,
controlled trial. N Engl J Med 1989; 321: 1501-1506[
Medline].
11.Marcellin P, Boyer N, Giostra E, Degott C,
Couroucé AM, Degos F, Coppere H, et al. Recombinant human
alpha-interferon in patients with chronic non-A, non-B hepatitis: a
multicenter randomized controlled trial from France. HEPATOLOGY
1991; 13: 601-603[
Medline].
12.Poynard T, Leroy V, Cohard M, Thevenot T, Mathurin P,
Opolon P, Zarski JP. Meta-analysis of interferon randomized trials
in the treatment of viral hepatitis C: effects of dose and
duration. HEPATOLOGY 1996; 24: 778-789[
Abstract].
13.Shindo M, Di Bisceglie AM, Hoofnagle JH. Long-term
follow-up of patients with chronic hepatitis C treated with
alpha-interferon. HEPATOLOGY 1992; 15: 1013-1016[
Medline].
14.Fong T-L, Shindo M, Feinstone SM, Hoofnagle JH,
DiBisceglie AM. Detection of replicative intermediates of hepatitis
C viral RNA in liver and serum of patients with chronic hepatitis
C. J Clin Invest 1991; 88: 1058-1060[
Medline].
15.National Institutes of Health Consensus Development
Conference Panel. Statement: management of hepatitis C. HEPATOLOGY
1997; 26(Suppl.): 2S-10S[
Medline].
16.Nolte FS, Thurmond C, Fried MV. Pre-clinical
evaluation of Amplicor hepatitis C virus test for detection of
hepatitis C virus RNA. J Clin Microbiol 1995; 33: 1775-1778[
Abstract].
17.Tong MJ, Blatt LM, McHutchison JG, Co RL, Conrad A.
Prediction of response during interferon alfa 2b therapy in chronic
hepatitis C patients using viral and biochemical characteristics: a
comparison. HEPATOLOGY 1997; 26: 1640-1645[
Abstract].
18.Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght
B, Van Heuverswyn H, Maertens G. Typing of hepatitis C virus
isolates and characterization of new subtypes using a line probe
assay. J Gen Virol 1993; 74: 1093-1102[
Medline].
19.Simmonds P, Rose K, Graham S, Chan S-N, McOmish F, Dow
B, Follett E, et al. Mapping of serotype-specific epitopes in the
NS4 region of hepatitis C virus (HCV): use of type-specific
peptides to serologically differentiate infections with HCV types
1, 2, and 3. J Clin Microbiol 1993; 31: 1493-1503[
Abstract].
20.Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer
PJ. Classification of chronic hepatitis: diagnosis, grading and
staging. HEPATOLOGY 1994; 19: 1513-1520[
Medline].
21.Di Bisceglie AM, Conjeevaram HS, Fried MW, Sallie R,
Park Y, Yurdayin C, Swain M, et al. Ribavirin as therapy for
chronic hepatitis C: a randomized, double-blind, placebo-controlled
trial. Ann Intern Med 1995; 123: 897-903[
Medline].
22.Fong T-L, Di Bisceglie AM, Gerber MA, Waggoner JG,
Hoofnagle JH. Persistence of hepatitis B virus DNA in the liver
after loss of HBsAg in chronic hepatitis B. HEPATOLOGY 1993; 18:
1313-1318[
Medline].
23.Saracco G, Rosina F, Abate ML, Chiandussi L, Gallo V,
Cerutti E, Di Napoli A, et al. Long-term follow up of patients with
chronic hepatitis C treated with different doses of interferon- 2b.
HEPATOLOGY 1993; 18: 1300-1305[
Medline].
24.Shindo N, Arai K, Sokawa Y, Okuno T. Hepatic hepatitis
C virus RNA as a predictor of a long-term response to interferon-
therapy. Ann Intern Med 1995; 122: 586-591[
Medline].
25.Marcellin P, Boyer N, Gervais A, Martinot M, Pouteau
M, Castelnau C, Kilani A, et al. Long-term histologic improvement
and loss of detectable intrahepatic HCV RNA in patients with
chronic hepatitis C and sustained response to interferon- therapy.
Ann Intern Med 1997; 127: 875-881[
Medline].
26.Cammà C, Di Marco V, Lo Iacono O, Almasio P,
Giunta M, Fuschi P, Vaccaro A, Fabiano C, Magrin S, Di Stefano R,
Bonura C, Pagliaro L, Craxi A. Long-term course of
interferon-treated chronic hepatitis C. J Hepatology 1998; 28:
531-537[
Medline].
27.Carithers Jr RL, Emerson SS. Therapy of hepatitis C:
meta-analysis of alfa-2b trials. HEPATOLOGY 1997; 26(Suppl.):
78S-82S[
Medline].
28.Lee WM. Therapy of hepatitis C: interferon alfa-2a
trials. HEPATOLOGY 1997; 26(Suppl.): 89S-95S[
Medline].
29.Farrell GC. Therapy of hepatitis C: interferon alfa-n1
trials. HEPATOLOGY 1997; 26(Suppl.): 96S-100S[
Medline].
30.Tong MJ, Reddy KR, Lee WM, Pockros PJ, Hoefs JC,
Keeffe EB, Hollinger FB, Heathcote EJ, White H, Foust RT, Jensen
DM, Krawitt EL, Fromm H, Black M, Blatt LM, Klein M, Lubina J, the
Consensus Interferon Study Group. Treatment of chronic hepatitis C
with consensus interferon: a multicenter, randomized, controlled
trial. HEPATOLOGY 1997; 26: 747-754[
Abstract].
31.Seeff LB. Natural history of hepatitis C. HEPATOLOGY
1997; 26(Suppl.): 21S-28S[
Medline].
32.Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical
outcomes after transfusion-associated hepatitis C. N Engl J Med
1995; 332: 1463-1466[
Medline].
0270-9139/98/2804-0030$3.00/0
Return To Article
table Of Contents
|